ATIM-16. nivolumab combined with radiotherapy with or without temozolmide in patients with newly diagnosed glioblastoma: results from phase 1 safety cohorts in CHECKMATE 143

Central Nervous System TumorsRadio-Oncology
Do you want to read an article? Please log in or register.